• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection
  • News
  • Opinion
  • About
  • Glossary

deep learning

Deep Learning, Machine Learning, and Artificial Intelligence – What are the Differences?

March 18, 2018 by Jose Rossello 1 Comment

In this video, Bernardo F. Nunes explains how these 3 concepts (artificial intelligence, machine learning, and deep learning) do not represent the same thing:

Bernardo is breaking down the 3 concepts for us, in a very easy and understandable way.

Artificial intelligence exists when a machine has cognitive capabilities, such as problem solving and learning. It’s normally associated to a human benchmark, as, for example reasoning, speech, and vision.

In the video, he differentiates 3 levels of A.I.:

  1. Narrow A.I., when a machine is better than us in a specific task (we are here now)
  2. General A.I., when a machine is like us in any intellectual task
  3. Strong A.I, when a machine is better than us in many tasks

One of the favorites early developments in A.I. is the perceptron (1957). It was a single layer of artificial neural networks designed for image recognition. They are called neural networks because the first practitioners on A.I. thought that these interconnected nodes looked like the human neural system, which has neural networks. These are the natural neural networks. The perceptron is a rudimentary version of an artificial neural network.

Machine learning, appeared on the 1980s, when a body of researchers worked on what is called supervised learning. Algorithms are trained with datasets based on past examples, in a model in which the trained algorithm is applied to a new dataset for classification purposes. Widely used for business purposes.

Deep learning makes use of deep neural networks. Shallow neural nets have only one hidden layer between the input and the output. However, deep neural nets have 2 or more hidden layers between the input and the output. It’s the responsible for the advancement in image recognition. If you can represent an image numerically, then you can process it with deep learning.

Bernardo’s conclusion is that deep learning, machine learning, and artificial intelligence are not 3 different things. They simply are subsamples of each other: deep learning belongs to machine learning, and machine learning belongs to artificial intelligence.

Jose Rossello
Jose Rossello

Filed Under: PV Analytics Tagged With: AI, artificial intelligence, deep learning, machine learning

Primary Sidebar

Subscribe in a reader

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Future of Regulatory Compliance: Navigating AI Advancements

As artificial intelligence (AI) continues to evolve and integrate into every … [Read More...] about Future of Regulatory Compliance: Navigating AI Advancements

AI Tools for Pharmacovigilance Data Analysis: Enhancing Drug Safety Monitoring

Artificial intelligence (AI) is revolutionizing the field of pharmacovigilance, … [Read More...] about AI Tools for Pharmacovigilance Data Analysis: Enhancing Drug Safety Monitoring

Predictive Models for Identifying Drug Risks: Enhancing Pharmaceutical Safety

In the field of healthcare, leveraging the power of predictive models to … [Read More...] about Predictive Models for Identifying Drug Risks: Enhancing Pharmaceutical Safety

Introduction to NLP in Pharmacovigilance: Enhancing Drug Safety Monitoring

Natural Language Processing (NLP) has become a pivotal tool in the realm of … [Read More...] about Introduction to NLP in Pharmacovigilance: Enhancing Drug Safety Monitoring

Overview of Machine Learning Models in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in public health by ensuring the safety … [Read More...] about Overview of Machine Learning Models in Pharmacovigilance: Enhancing Drug Safety Monitoring

AI and Real-Time Drug Safety Monitoring: Revolutionizing Pharmacovigilance Practices

Artificial intelligence (AI) is transforming the landscape of drug safety by … [Read More...] about AI and Real-Time Drug Safety Monitoring: Revolutionizing Pharmacovigilance Practices

AI’s Role in Identifying Adverse Drug Reactions: Enhancing Pharmacovigilance Systems

Artificial intelligence (AI) is becoming an indispensable tool in healthcare, … [Read More...] about AI’s Role in Identifying Adverse Drug Reactions: Enhancing Pharmacovigilance Systems

Key AI Technologies in Drug Safety Monitoring: Revolutionizing Pharma Vigilance

The integration of artificial intelligence (AI) technologies into the realm of … [Read More...] about Key AI Technologies in Drug Safety Monitoring: Revolutionizing Pharma Vigilance

Evolution of Drug Safety: Tracing the Shift to AI-Driven Methodologies

Ensuring the safety of pharmaceutical drugs is a complex challenge that has … [Read More...] about Evolution of Drug Safety: Tracing the Shift to AI-Driven Methodologies

Introduction to AI in Drug Safety Monitoring: Revolutionizing Pharmacovigilance

Artificial Intelligence (AI) has emerged as a transformative force in the realm … [Read More...] about Introduction to AI in Drug Safety Monitoring: Revolutionizing Pharmacovigilance

  • The Proportional Reporting Ratio According to ChatGPT
  • Explainable Artificial Intelligence and Pharmacovigilance
  • Analysis Of Textual Data May Complement Traditional Pharmacovigilance

RSS From Nature journal

  • Lower cardiotoxicity of CPX-351 relative to daunorubicin plus cytarabine free-drug combination in hiPSC-derived cardiomyocytes in vitro
  • NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
  • Safety and efficacy of remimazolam compared with midazolam during bronchoscopy: a single-center, randomized controlled study
  • Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine
  • A generative adversarial network model alternative to animal studies for clinical pathology assessment

Copyright © 2023 · News Pro on Genesis Framework · WordPress · Log in